1162680-84-3

Basic information

• Product Name: N-(6-bromoH-imidazo[1,2-a]pyridin-2-yl)acetamide
• Synonyms: N-(6-bromoH-imidazo[1,2-a]pyridin-2-yl)acetamide
• CAS NO: 1162680-84-3
• Molecular Formula: C₉H₈BrN₃O
• Molecular Weight: 254.08332
• Mol File: 1162680-84-3.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-(6-bromoH-imidazo[1,2-a]pyridin-2-yl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(6-bromoH-imidazo[1,2-a]pyridin-2-yl)acetamide(1162680-84-3)
• EPA Substance Registry System: N-(6-bromoH-imidazo[1,2-a]pyridin-2-yl)acetamide(1162680-84-3)

Safety Data

• Hazardous Substances Data: 1162680-84-3(Hazardous Substances Data)

Upstream product

• 947248-52-4 6-bromoimidazole[1,2-a]pyridine-2-amine 
• 108-24-7 acetic anhydride 
• 1005785-49-8 2-[5-bromo-2-{[(4-methylphenyl)sulfonyl]imino}pyridin-1(2H)-yl]acetamide 
• 75-36-5 acetyl chloride 
• 504413-35-8 N-(6-bromoimidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoroacetamide 
• 937014-94-3 (Z)-2-(5-bromo-2-(tosylimino)pyridin-1(2H)-yl)acetamide 
• 1072-97-5 5-bromo-2-pyridylamine 
• 207801-52-3 N-(5-bromopyridin-2-yl)-4-methylbenzenesulfonamide 

Downstream Products

• 947249-08-3 N-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-2-yl)acetamide 
• 1162680-35-4 N-(6-(6-chloro-5-(4-fluorophenylsulfonamido)pyridin-3-yl)imidazo[1,2-a]pyridin-2-yl)acetamide 
• 1244055-68-2 N-[6-(3-{[(2-hydroxyethyl)amino]sulfonyl}phenyl)imidazo[1,2-a]pyridin-2-yl]acetamide 

Relevant articles and documents

HETEROARYL COMPOUNDS AS INHIBITORS OF NECROSIS, COMPOSITION AND APPLICATION THEREOF

The present disclosure provides heteroaryl compounds of formulas (I), (Ia) and (Ib), processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from or related to necrosi

FUSED BICYCLIC COMPOUNDS AS INHIBITORS FOR PI3 KINASE

The invention relates to compounds of formula (I) for the regulation of phosphoinositides 3-kinases activity and related diseases.

Inhibitors of PI3 kinase

The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt thereof, that inhibit phosphoinositide 3-kinase; methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds.